Pulmonary function tests and airway responsiveness to methacholine in chronic bronchiectasis of the adult
- PMID: 6383502
Pulmonary function tests and airway responsiveness to methacholine in chronic bronchiectasis of the adult
Abstract
Fifty adults with chronic bronchiectasis (mean duration since diagnosis: 25 +/- 16.4 years), excluding those cases secondary to tuberculosis or hypogammaglobulinemia, were investigated by a questionnaire, a chest radiograph and lung function tests. Of these, 29 with an FEV1 greater than 1.5 1 underwent methacholine inhalation tests. Fourty-three subjects and three subjects respectively showed an obstructive or a mixed obstructive and restrictive defect, only four having normal lung function tests. Sixty-nine percent of subjects tested had a provocative concentration of methacholine causing a 20% fall in FEV1 (PC20) less than 16 mg X ml-1. Subjects with daily sputum production had lower values of FEV1 and FEV1/forced vital capacity (FVC) compared to subjects with less than daily sputum. Subjects with clinical features of bronchial hyperexcitability had significantly lower baseline FEV1, vital capacity, and maximal mid-expiratory flow rate (FEF25-75). Subjects with lower PC20 values had significantly lower baseline FEV1, FEV1/FVC and FEF25-75. Finally, subjects with the greatest extent of radiological abnormalities had lower baseline FEV1, FEV1/FVC and diffusing capacity, and a higher residual volume. We conclude that chronic bronchiectasis is associated with significant changes in lung function tests and increased responsiveness to methacholine in the majority of affected individuals.
Similar articles
-
Nonallergic bronchial hyperexcitability in chronic bronchitis.Am Rev Respir Dis. 1984 Feb;129(2):216-20. Am Rev Respir Dis. 1984. PMID: 6364903
-
Relationship between airway responsiveness and peak expiratory flow variability in subjects with allergic rhinitis.Ann Allergy Asthma Immunol. 1995 Sep;75(3):273-9. Ann Allergy Asthma Immunol. 1995. PMID: 7552931
-
Attenuating effect of a thromboxane synthetase inhibitor (OKY-046) on bronchial responsiveness to methacholine is specific to bronchial asthma.Chest. 1990 Sep;98(3):656-60. doi: 10.1378/chest.98.3.656. Chest. 1990. PMID: 2203618
-
A stepwise approach to the interpretation of pulmonary function tests.Am Fam Physician. 2014 Mar 1;89(5):359-66. Am Fam Physician. 2014. PMID: 24695507 Review.
-
[Bronchiectasis].Nihon Rinsho. 1999 Sep;57(9):2113-8. Nihon Rinsho. 1999. PMID: 10497415 Review. Japanese.
Cited by
-
The effects of bronchiectasis on asthma exacerbation.Tuberc Respir Dis (Seoul). 2014 Nov;77(5):209-14. doi: 10.4046/trd.2014.77.5.209. Epub 2014 Nov 28. Tuberc Respir Dis (Seoul). 2014. PMID: 25473408 Free PMC article.
-
Analysis of factors associated with bronchial hyperreactivity to methacholine in bronchiectasis.Lung. 1991;169(1):43-51. doi: 10.1007/BF02714140. Lung. 1991. PMID: 2011043
-
Nebulisers for bronchiectasis.Thorax. 1997 Apr;52 Suppl 2(Suppl 2):S72-4. doi: 10.1136/thx.52.2008.s72. Thorax. 1997. PMID: 9155857 Free PMC article. No abstract available.
-
Prevalence of asthma, atopy, and bronchial hyperreactivity in bronchiectasis: a controlled study.Thorax. 1989 Nov;44(11):948-51. doi: 10.1136/thx.44.11.948. Thorax. 1989. PMID: 2595637 Free PMC article.
-
Is there a role for inhaled corticosteroids and macrolide therapy in bronchiectasis?Drugs. 2007;67(7):965-74. doi: 10.2165/00003495-200767070-00002. Drugs. 2007. PMID: 17488142 Review.